Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 35

Sort by

Sort Order Select

Journal Articles

CAR T cell-driven induction of iNOS in tumor associated macrophages promotes CAR T cell resistance in B cell lymphoma

Blood (2025) 146 (Supplement 1): 558.

https://doi.org/10.1182/blood-2025-558

Published: 2025

Journal Articles

Comparison of infections in patients with chronic lymphocytic leukemia (CLL) treated with BTKi versus venetoclax obinutuzumab in first line therapy

Jawria Tufail, Zubair Hassan Bodla, Matthew Cortese, Muhammad Junaid Tariq

Blood (2025) 146 (Supplement 1): 3884.

https://doi.org/10.1182/blood-2025-3884

Published: 2025

Journal Articles

In-depth, quantitative characterization of important regulators and predictive biomarkers for CAR T-cell therapy induced toxicities in a clinical cohort

Min Ma, Muhammad Junaid Tariq, Showkat Hamid, Shannon McSain, Ming Zhang, Maosheng Wei, Erfei Shang, Yingyi Lian, Meredith Stone, Spencer Rosario, Jun Qu, Marco Davila

Blood (2025) 146 (Supplement 1): 4141.

https://doi.org/10.1182/blood-2025-4141

Published: 2025

Journal Articles

Characteristics and therapies for pure red cell aplasia in patients with chronic lymphocytic leukemia (CLL) - a real world analysis from trinetx database

Jawria Tufail, Muhammad Junaid Tariq

Blood (2025) 146 (Supplement 1): 5689.

https://doi.org/10.1182/blood-2025-5689

Published: 2025

Journal Articles

Real world outcomes in patients with acquired thrombotic thrombocytopenic purpura (TTP) treated with caplacizumab

Jawria Tufail, Zubair Hassan Bodla, Muhammad Junaid Tariq

Blood (2025) 146 (Supplement 1): 3106.

https://doi.org/10.1182/blood-2025-3106

Published: 2025

Journal Articles

Correlation of Serum Inflammatory State and Macrophage Phenotype with CAR T Cell Expansion and Clinical Outcomes

Showkat Hamid, Muhammad Junaid Tariq, SaeBom Lee, Payal Goala, Shannon McSain, Cooper Sailer, Nolan Beatty, Marco Davila

Blood (2024) 144 (Supplement 1): 3432.

https://doi.org/10.1182/blood-2024-212112

Published: 2024

Journal Articles

Clinical Outcomes of Lymphoplasmacytic Lymphoma / Waldenstrom Macroglobulinemia (LPL/WM) in the Targeted Therapy Era: A US Multicenter Retrospective Analysis

Blood (2024) 144 (Supplement 1): 4392.

https://doi.org/10.1182/blood-2024-199278

Published: 2024

Journal Articles

RSV Pneumonia Mortality: Hematological Malignancies As a Silent Amplifier - Insights from the National Inpatient Sample 2020

Zubair Hassan Bodla, Mariam Hashmi, Fatima Niaz, Austin Auyeung, Muhammad Junaid Tariq, Muhammad Jahanzeb Khalil, Farhan Khalid, Christopher Bray

Blood (2023) 142 (Supplement 1): 4203.

https://doi.org/10.1182/blood-2023-185046

Published: 2023

Journal Articles

Decoding the DIC-Lymphoma Relationship: A Nationwide Analysis of Increased Risk in Adult Patients

Zubair Hassan Bodla, Mariam Hashmi, Fatima Niaz, Muhammad Junaid Tariq, Zahra Niaz, Christopher Bray

Blood (2023) 142 (Supplement 1): 6134.

https://doi.org/10.1182/blood-2023-185143

Published: 2023

Journal Articles

Treatment Selection and Clinical Outcomes in Lymphoplasmacytic Lymphoma/Waldenstrom Macroglobulinemia (LPL/WM) - a Single Center Analysis

Muhammad Junaid Tariq, Andrea Carolina Anampa-Guzmán, Malak Alharbi, Khalid Shalaby, Riya Patel, Showkat Hamid, Anthony George, Kristopher Attwood, Francisco J. Hernandez-Ilizaliturri, Matthew J Cortese

Blood (2023) 142 (Supplement 1): 4421.

https://doi.org/10.1182/blood-2023-181306

Published: 2023

Journal Articles

Frequency, Histologic, and Prognostic Significance of CD30 Expression in AIDS-associated Diffuse Large B-Cell Lymphoma

Amina Chaudhry, Muhammad Junaid Tariq, Eshana Shah, Camille E. DeMarco, Erin G. Reid, Ethel Cesarman, Amy Chadburn, Paul Rubinstein

Blood (2021) 138 (Supplement 1): 1447.

https://doi.org/10.1182/blood-2021-154030

Published: 2021

Journal Articles

Efficacy and Safety of Selinexor for Acute Myeloid Leukemia: A Systematic Review

Mydah Sajid Hashmi, MD, Muhammad Ans Sharif, MBBS, Ali Jaan, MD, Umer Salman, MBBS, Summera Aziz, Asna Shahab, Zahoor Ahmed, MD, Muhammad Junaid Tariq, MD, Mobeen Zaka Haider, MDMBBS, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 15–16.

https://doi.org/10.1182/blood-2020-141050

Published: 2020

Journal Articles

Prevalence of Major Depression Among Cancer Patients: Single Center Tertiary Care Hospital Experience from Lahore, Pakistan

Arafat Ali Farooqui, MD, Muhammad Waqas, MD, Aqsa Iftikhar, MBBS, Muhammad Junaid Tariq, MD, Faiz Anwer, MD

Blood (2019) 134 (Supplement_1): 5784.

https://doi.org/10.1182/blood-2019-123345

Published: 2019

Journal Articles

Comparative Efficacy and Safety of Once Versus Twice Weekly Carfilzomib Based Therapies in Relapsed Refractory Multiple Myeloma- a Systematic Review

Saif Ur Rehman, MBBS, MD, Saad Sharif, MBBS, MD, Syeda Sabeeka Batool, MBBS, MD, Hamza Bajwa, MBBS, MD, Arafat Ali Ali Farooqui, MD, Zahoor Ahmed, MBBS, MD, Ahmad Anjum, MD, Talha Bin Farooq, MD, Samana Mukhtar, MBBS, MD, Sibgha Gull Chaudhary, MD, Muhammad Junaid Tariq, MD, Tariq Iqtidar Sadiq Syed, MD, Syed Maaz Abdullah, MBBS, Muhammad Salman Faisal, MD MBBS, Faiz Anwer, MD

Blood (2019) 134 (Supplement_1): 3150.

https://doi.org/10.1182/blood-2019-132081

Published: 2019

Journal Articles

Antibody Based Three-Drug Regimens for Multiple Myeloma - a Systematic Review of Phase II and Phase III Clinical Trials

Arafat Ali Farooqui, MD, Humaira Sarfraz, MD, Zunairah Shah, MBBS, Muhammad Saad Farooqi, MD, Maimoona Khan, MBBS, Aqsa Ashraf, MD, Ahmad Anjum, MD, Talha Bin Farooq, MD, Tanveer Shaukat, MD, Ali Younas Khan, MD, Madeeha Shafqat, Muhammad Junaid Tariq, MD, Faiz Anwer, MD

Blood (2019) 134 (Supplement_1): 5546.

https://doi.org/10.1182/blood-2019-121999

Published: 2019

Journal Articles

Efficacy of Elotuzumab Based Combinations in Patients with Multiple Myeloma - a Systematic Review

Arafat Ali Farooqui, MD, Ahmad Anjum, MD, Muhammad Saad Farooqi, MD, Talha Bin Farooq, MD, Tanveer Shaukat, MD, Aqsa Ashraf, MD, Humaira Sarfraz, MD, Zunairah Shah, MBBS, Muhammad Junaid Tariq, MD, Faiz Anwer, MD

Blood (2019) 134 (Supplement_1): 5548.

https://doi.org/10.1182/blood-2019-122395

Published: 2019

Journal Articles

Three Drug Regimens for Newly Diagnosed Multiple Myeloma Transplant-Ineligible Elderly Patients - a Systematic Review

Abdul Aziz Siddiqui, MD, Kazi Najamus-saqib Khan, Arafat Ali Farooqui, MD, Muhammad Saad Farooqi, MD, Muhammad Junaid Tariq, MD, Faiz Anwer, MD

Blood (2019) 134 (Supplement_1): 5574.

https://doi.org/10.1182/blood-2019-132095

Published: 2019

Journal Articles

Clinical Response and Tolerability of Selinexor in Acute Myeloid Leukemia and Other Hematologic Malignancies - a Systematic Review

Muhammad Junaid Tariq, MD, Muhammad Yasir, MD, Amna Khalid, MD, Saher Nasir Amin, MD, Sharoon Samuel, MBBS, Muhammad Jahanzeb Khalil, MD, Shehroz Aslam, MD, Malik Qistas Ahmad, MD MBBS, Muhammad Asad Fraz, MD, Muhammad Usman, MD, Awais Ijaz, MD, Arafat Ali Farooqui, MBBS, Seren Durer, MD, Ceren Durer, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5231.

https://doi.org/10.1182/blood-2018-99-116819

Published: 2018

Journal Articles

Myelofibrosis Drug Development through the Decade: Novel JAK Inhibitors

Ali Younas Khan, MD, Muhammad Junaid Tariq, MD, Muhammad Usman, MD, Awais Ijaz, MD, Abdul Rafae, MD, Mustafa Nadeem Malik, MD, Hafiz Muhammad Fazeel, MD, Nadia Carenina Nunes Cavalcante Parr, MD, Muhammad Asad Fraz, MD, Muhammad Jahanzeb Khalil, MD, Jemin Aby Jose, MD, Seren Durer, MD, Ceren Durer, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5477.

https://doi.org/10.1182/blood-2018-99-115408

Published: 2018

Journal Articles

Presentation Pattern, Diagnostic Markers, Management and Outcome of IgD Multiple Myeloma: A Systematic Review

Insija Ilyas Selene, MBBS, Jemin Aby Jose, MD, Muhammad Jahanzeb Khalil, MD, Muhammad Junaid Tariq, MD, Seren Durer, MD, Ceren Durer, MD, Madeeha Shafqat, Shehroz Aslam, MD, Zunairah Shah, MBBS, Anum Qureshi, Faiza Jamil, MD, Mustafa Nadeem Malik, MD, Abdul Rafae, MD, Muhammad Masab, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 3309.

https://doi.org/10.1182/blood-2018-99-116959

Published: 2018

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

CAR T cell-driven induction of iNOS in tumor associated macrophages promotes CAR T cell resistance in B cell lymphoma

Comparison of infections in patients with chronic lymphocytic leukemia (CLL) treated with BTKi versus venetoclax obinutuzumab in first line therapy

In-depth, quantitative characterization of important regulators and predictive biomarkers for CAR T-cell therapy induced toxicities in a clinical cohort

Characteristics and therapies for pure red cell aplasia in patients with chronic lymphocytic leukemia (CLL) - a real world analysis from trinetx database

Real world outcomes in patients with acquired thrombotic thrombocytopenic purpura (TTP) treated with caplacizumab

Correlation of Serum Inflammatory State and Macrophage Phenotype with CAR T Cell Expansion and Clinical Outcomes

Clinical Outcomes of Lymphoplasmacytic Lymphoma / Waldenstrom Macroglobulinemia (LPL/WM) in the Targeted Therapy Era: A US Multicenter Retrospective Analysis

RSV Pneumonia Mortality: Hematological Malignancies As a Silent Amplifier - Insights from the National Inpatient Sample 2020

Decoding the DIC-Lymphoma Relationship: A Nationwide Analysis of Increased Risk in Adult Patients

Treatment Selection and Clinical Outcomes in Lymphoplasmacytic Lymphoma/Waldenstrom Macroglobulinemia (LPL/WM) - a Single Center Analysis

Frequency, Histologic, and Prognostic Significance of CD30 Expression in AIDS-associated Diffuse Large B-Cell Lymphoma

Efficacy and Safety of Selinexor for Acute Myeloid Leukemia: A Systematic Review

Prevalence of Major Depression Among Cancer Patients: Single Center Tertiary Care Hospital Experience from Lahore, Pakistan

Comparative Efficacy and Safety of Once Versus Twice Weekly Carfilzomib Based Therapies in Relapsed Refractory Multiple Myeloma- a Systematic Review

Antibody Based Three-Drug Regimens for Multiple Myeloma - a Systematic Review of Phase II and Phase III Clinical Trials

Efficacy of Elotuzumab Based Combinations in Patients with Multiple Myeloma - a Systematic Review

Three Drug Regimens for Newly Diagnosed Multiple Myeloma Transplant-Ineligible Elderly Patients - a Systematic Review

Clinical Response and Tolerability of Selinexor in Acute Myeloid Leukemia and Other Hematologic Malignancies - a Systematic Review

Myelofibrosis Drug Development through the Decade: Novel JAK Inhibitors

Presentation Pattern, Diagnostic Markers, Management and Outcome of IgD Multiple Myeloma: A Systematic Review

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only